1 |
Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac Disease |
US12623957 |
2009-11-23 |
US20100248270A1 |
2010-09-30 |
Yossi Cohen; Alexander Diber; Amir Toporik; Sarah Pollock; Zurit Levine; Michal Ayalon-Soffer; Gad S. Cojocaru; Amit Novik; Guy Kol; Osnat Sella-Tavor; Shira Walach; Shirley Sameah-Greenwald; Dvir Dahary; Ronen Shemesh |
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states. |
2 |
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease |
US11978203 |
2007-10-29 |
US07714100B2 |
2010-05-11 |
Yossi Cohen; Alexander Diber; Amir Toporik; Sarah Pollock; Zurit Levine; Michal Ayalon-Soffer; Gad S. Cojocaru; Amit Novik; Guy Kol; Osnat Sella-Tavor; Shira Walach; Shirley Sameah-Greenwald; Dvir Dahary; Ronen Shemesh |
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states. |
3 |
Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease |
US11978203 |
2007-10-29 |
US20080193941A1 |
2008-08-14 |
Yossi Cohen; Alexander Diber; Amir Toporik; Sarah Pollock; Zurit Levine; Michal Avalon-Soffer; Gad S. Cojocaru; Amit Novik; Guy Kol; Osnat Sella-Tavor; Shira Walach; Shirley Sameah-Greenwald; Dvir Dahary; Ronen Shemesh |
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states. |
4 |
METHODS OF DETECTION AND TREATMENT FOR CARDIOVASCULAR DISEASE AND FOOT WOUNDS |
US15967719 |
2018-05-01 |
US20180321225A1 |
2018-11-08 |
Mohamed Zayed; Clay Semenkovich |
Among the various aspects of the present disclosure is the provision of a method of detection, treatment, and monitoring of cardiovascular disease or a foot wound by detection of a novel biomarker, Fatty Acid Synthase (FAS). |
5 |
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease |
US11043824 |
2005-01-27 |
US07345142B2 |
2008-03-18 |
Yossi Cohen; Alexander Diber; Amir Toporik; Sarah Pollock; Zurit Levine; Michal Ayalon-Soffer; Gad S. Cojocaru; Amit Novik; Guy Kol; Osnat Sella-Tavor; Shira Walach; Shirley Sameah-Greenwald; Dvir Dahary; Ronen Shemesh |
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states. |
6 |
Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease |
US11043824 |
2005-01-27 |
US20060172311A1 |
2006-08-03 |
Yossi Cohen; Alexander Diber; Amir Toporik; Sarah Pollock; Zurit Levine; Michal Ayalon-Soffer; Gad Cojocaru; Amit Novik; Guy Kol; Osnat Sella-Tavor; Shira Walach; Shirley Sameah-Greenwald; Dvir Dahary; Ronen Shemesh |
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states. |